KOREA PHARMA Co., Ltd.

KOSDAQ:A032300 Voorraadrapport

Marktkapitalisatie: ₩185.3b

KOREA PHARMA Beheer

Beheer criteriumcontroles 0/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Eun-Hee Park

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEOno data
Eigendom CEO16.7%
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuurgeen gegevens

Recente managementupdates

Geen updates

Recent updates

Is KOREA PHARMA (KOSDAQ:032300) A Risky Investment?

Nov 12
Is KOREA PHARMA (KOSDAQ:032300) A Risky Investment?

Optimistic Investors Push KOREA PHARMA Co., Ltd. (KOSDAQ:032300) Shares Up 29% But Growth Is Lacking

Oct 16
Optimistic Investors Push KOREA PHARMA Co., Ltd. (KOSDAQ:032300) Shares Up 29% But Growth Is Lacking

KOREA PHARMA (KOSDAQ:032300) Seems To Use Debt Quite Sensibly

Mar 26
KOREA PHARMA (KOSDAQ:032300) Seems To Use Debt Quite Sensibly

What You Need To Know About KOREA PHARMA Co., Ltd.'s (KOSDAQ:032300) Investor Composition

Jan 08
What You Need To Know About KOREA PHARMA Co., Ltd.'s (KOSDAQ:032300) Investor Composition

CEO

Eun-Hee Park (57 yo)

no data

Tenure

Ms. Eun-Hee Park is Chief Executive Officer & Director of KOREA PHARMA Co. Ltd.